Cubicin (Royalty rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Cubicin (Royalty rights) General Information

Description

A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Acquirer
Royalty Pharma
Corporate Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cubicin (Royalty rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cubicin (Royalty rights)‘s full profile, request access.

Request a free trial

Cubicin (Royalty rights) FAQs

  • Where is Cubicin (Royalty rights) headquartered?

    Cubicin (Royalty rights) is headquartered in .

  • What industry is Cubicin (Royalty rights) in?

    Cubicin (Royalty rights)’s primary industry is Buildings and Property.

  • Is Cubicin (Royalty rights) a private or public company?

    Cubicin (Royalty rights) is a Private company.

  • What is Cubicin (Royalty rights)’s current revenue?

    The current revenue for Cubicin (Royalty rights) is 000000.

  • When was Cubicin (Royalty rights) acquired?

    Cubicin (Royalty rights) was acquired on 01-Mar-2011.

  • Who acquired Cubicin (Royalty rights)?

    Cubicin (Royalty rights) was acquired by Royalty Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »